BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 16082217)

  • 1. The intracellular tyrosine kinase Brk sensitizes non-transformed cells to inducers of apoptosis.
    Haegebarth A; Nunez R; Tyner AL
    Cell Cycle; 2005 Sep; 4(9):1239-46. PubMed ID: 16082217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosine phosphorylation of sam68 by breast tumor kinase regulates intranuclear localization and cell cycle progression.
    Lukong KE; Larocque D; Tyner AL; Richard S
    J Biol Chem; 2005 Nov; 280(46):38639-47. PubMed ID: 16179349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brk, a breast tumor-derived non-receptor protein-tyrosine kinase, sensitizes mammary epithelial cells to epidermal growth factor.
    Kamalati T; Jolin HE; Mitchell PJ; Barker KT; Jackson LE; Dean CJ; Page MJ; Gusterson BA; Crompton MR
    J Biol Chem; 1996 Nov; 271(48):30956-63. PubMed ID: 8940083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Building a better understanding of the intracellular tyrosine kinase PTK6 - BRK by BRK.
    Brauer PM; Tyner AL
    Biochim Biophys Acta; 2010 Aug; 1806(1):66-73. PubMed ID: 20193745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRK phosphorylates PSF promoting its cytoplasmic localization and cell cycle arrest.
    Lukong KE; Huot ME; Richard S
    Cell Signal; 2009 Sep; 21(9):1415-22. PubMed ID: 19439179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered localization and activity of the intracellular tyrosine kinase BRK/Sik in prostate tumor cells.
    Derry JJ; Prins GS; Ray V; Tyner AL
    Oncogene; 2003 Jul; 22(27):4212-20. PubMed ID: 12833144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of breast tumour kinase in the in vitro differentiation of HaCaT cells.
    Wang TC; Jee SH; Tsai TF; Huang YL; Tsai WL; Chen RH
    Br J Dermatol; 2005 Aug; 153(2):282-9. PubMed ID: 16086737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast tumor kinase phosphorylates p190RhoGAP to regulate rho and ras and promote breast carcinoma growth, migration, and invasion.
    Shen CH; Chen HY; Lin MS; Li FY; Chang CC; Kuo ML; Settleman J; Chen RH
    Cancer Res; 2008 Oct; 68(19):7779-87. PubMed ID: 18829532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRK targets Dok1 for ubiquitin-mediated proteasomal degradation to promote cell proliferation and migration.
    Miah S; Goel RK; Dai C; Kalra N; Beaton-Brown E; Bagu ET; Bonham K; Lukong KE
    PLoS One; 2014; 9(2):e87684. PubMed ID: 24523872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the Brk SH3 domain in substrate recognition.
    Qiu H; Miller WT
    Oncogene; 2004 Mar; 23(12):2216-23. PubMed ID: 14676834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of the nonreceptor tyrosine kinase Brk by autophosphorylation and by autoinhibition.
    Qiu H; Miller WT
    J Biol Chem; 2002 Sep; 277(37):34634-41. PubMed ID: 12121988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast tumor kinase (Brk/PTK6) plays a role in the differentiation of primary keratinocytes.
    Tupper J; Crompton MR; Harvey AJ
    Arch Dermatol Res; 2011 May; 303(4):293-7. PubMed ID: 21240512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BRK tyrosine kinase expression in a high proportion of human breast carcinomas.
    Barker KT; Jackson LE; Crompton MR
    Oncogene; 1997 Aug; 15(7):799-805. PubMed ID: 9266966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation and chromosome mapping of the human non receptor tyrosine kinase gene, brk.
    Mitchell PJ; Barker KT; Shipley J; Crompton MR
    Oncogene; 1997 Sep; 15(12):1497-502. PubMed ID: 9333026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brk is coamplified with ErbB2 to promote proliferation in breast cancer.
    Xiang B; Chatti K; Qiu H; Lakshmi B; Krasnitz A; Hicks J; Yu M; Miller WT; Muthuswamy SK
    Proc Natl Acad Sci U S A; 2008 Aug; 105(34):12463-8. PubMed ID: 18719096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRK/Sik expression in the gastrointestinal tract and in colon tumors.
    Llor X; Serfas MS; Bie W; Vasioukhin V; Polonskaia M; Derry J; Abbott CM; Tyner AL
    Clin Cancer Res; 1999 Jul; 5(7):1767-77. PubMed ID: 10430081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin.
    Chen HY; Shen CH; Tsai YT; Lin FC; Huang YP; Chen RH
    Mol Cell Biol; 2004 Dec; 24(24):10558-72. PubMed ID: 15572663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast tumor kinase/protein tyrosine kinase 6 (Brk/PTK6) activity in normal and neoplastic biliary epithelia.
    Mizuguchi Y; Specht S; Isse K; Sasatomi E; Lunz JG; Takizawa T; Demetris AJ
    J Hepatol; 2015 Aug; 63(2):399-407. PubMed ID: 25770659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast tumor kinase BRK requires kinesin-2 subunit KAP3A in modulation of cell migration.
    Lukong KE; Richard S
    Cell Signal; 2008 Feb; 20(2):432-42. PubMed ID: 18077133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brk protects breast cancer cells from autophagic cell death induced by loss of anchorage.
    Harvey AJ; Pennington CJ; Porter S; Burmi RS; Edwards DR; Court W; Eccles SA; Crompton MR
    Am J Pathol; 2009 Sep; 175(3):1226-34. PubMed ID: 19661439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.